Company NeuroOne Medical Technologies Corporation Other OTC

Equities

NMTC

US64130M1009

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Medical Diagnostic & Testing Equipment

NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

USD in Million	2022	Weight	2023	Weight	Delta
Strip/Grid Products, Stereoelectrocencephalography Products and Electrode Cable Assembly Products 57.3 %	0	8.1 %	2	57.3 %	+1,040.65%
Collaborations 42.7 %	2	91.9 %	1	42.7 %	-25.33%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	2	100.0 %	3	100.0 %	+60.73%

Managers	Title	Age	Since
Mark Christanson FOU	Founder	56	19/08/09
David Rosa CEO	Chief Executive Officer	59	19/07/17
Ronald McClurg DFI	Director of Finance/CFO	65	31/12/20
Christopher Volker COO	Chief Operating Officer	53	11-09
Steven Mertens CTO	Chief Tech/Sci/R&D Officer	61	14/04/19
Chad Wilhelmy LAW	General Counsel	-	17/01/22
Hijaz Haris SAM	Sales & Marketing	-	26/04/21

Members of the board	Title	Age	Since
Paul Buckman CHM	Chairman	68	03/08/17
Jeffrey Mathiesen BRD	Director/Board Member	63	03/08/17
Edward Andrle BRD	Director/Board Member	66	17/02/20
David Rosa CEO	Chief Executive Officer	59	19/07/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	27,515,921	22,796,606 ( 82.85 %)	0	82.85 %

Name	Equities	%	Valuation
Manchester Management Co. LLC 9.117 %	2,364,052	9.117 %	3 M $
AWM Investment Co., Inc. 5.592 %	1,450,000	5.592 %	2 M $
Laurence Lytton 5.029 %	1,304,102	5.029 %	1 M $
Nantahala Capital Management LLC 4.682 %	1,214,094	4.682 %	1 M $
David Rosa 4.483 %	1,162,597	4.483 %	1 M $
Vanguard Group, Inc. (Subfiler) 3.545 %	919,321	3.545 %	1 M $
Mark Christanson 1.246 %	323,114	1.246 %	358 657 $
Ronald McClurg 0.9414 %	244,117	0.9414 %	270 970 $
Geode Capital Management LLC 0.8559 %	221,949	0.8559 %	246 363 $
Mayo Medical Ventures 0.7009 %	181,754	0.7009 %	201 747 $

NeuroOne Medical Technologies Corp.

7599 Anagram Drive

55344, Eden Prairie

http://www.n1mtc.com

address NeuroOne Medical Technologies Corporation(NMTC)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-41.29%	2.95B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+18.54%	1.88B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-2.22%	1.63B
BIOTAGE AB	+34.41%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.73%	959M
CONTEC MEDICAL SYSTEMS CO.,LTD	-22.64%	888M
REVENIO GROUP OYJ	+6.92%	842M
VAREX IMAGING CORPORATION	-25.37%	623M
CELLAVISION AB	+11.08%	513M

Medical Diagnostic & Testing Equipment